The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
Minneapolis, MN, USA and Paris, France and Munich, Germany, 7 April 2026 – TRiCares SAS (“TRiCares”), a privately held pioneer in the field of ...
In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug development: high costs and long timelines. Providing clarity around modern ...
In April 2026, XellSmart officially launches its multicenter Phase II registrational clinical trial of the Clinical-Grade, ...
RMAT designation enables intensified FDA engagement and potential accelerated pathways, implying preliminary clinical evidence for RTx-015 despite absent peer-reviewed efficacy details, endpoints, and ...
The risks and benefits of hormone replacement therapy use for menopausal symptoms in breast cancer survivors are examined in light of recent research.
AI analysis of Reddit posts uncovered potential side effects of GLP-1 drugs that may be underreported, demonstrating the value of social media in early drug safety insights.
VDYNE, Inc. (“VDYNE” or “the Company”), a privately held medical device company developing next generation transcatheter valve replacement technologies, today announced that the U.S. Food & Drug ...
SnoreRX examines its FDA-cleared mandibular advancement mouthpiece design, 1-millimeter adjustable calibration, boil-and-bite ...
Grant is an M.D./M.B.A. student at Harvard Medical School and Harvard Business School, a researcher at Boston Children’s ...
The FDA office that regulates vaccines and gene therapies has been a hornet’s nest during the tenure of Dr. Vinay Prasad, who ...
A living, 3D-printed knee joint made from biodegradable scaffolding infused with stem cells has met all milestones to move ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results